Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $13.85 Analyst target: $10.33 Upside: -25.42%
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
See the full interactive analysis & chart →Informational only — not investment advice.